Inno-Gene SA operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Inno-Gene SA with three other
miscellaneous service companies in Europe:
Kuros Biosciences AG
sales of 534,000.00 Swiss Francs [US$535,068.00 ]
Medical Prognosis Institute A/S
(5.15 million Danish Kroner [US$813,167.25 ]
Shield Therapeutics PLC
based in the United Kingdom
(£637,000.00 [US$858,491.27 ]
During the year ended December of 2017, sales at
Inno-Gene SA were 2.92 million Polish New Zlotys (US$800.37 thousand).
decrease of 37.3%
versus 2016, when the company's sales were 4.67 million Polish New Zlotys.